alexa
Reach Us +44-1764-910199
Editor - Giulia Cantini | University of Florence | 25375

Journal of Diabetes & Clinical Practice
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Giulia Cantini

Giulia Cantini
Giulia Cantini
Department of Experimental and Clinical Biomedical Sciences
University of Florence
Italy 
University of Florence

Biography

Giulia Cantini is a biologist and a Post-Doc Fellow. For ten years, she has been working in the field of endocrinology at the University of Florence. She is author and co-author of more than 20 articles in peer-review journals, and she is acting as referee for a number of journals. She also supervised the training and thesis of over 10 students.
Her research matter has been grown in the endocrinological field, and range over the physiopathology of adipose tissue up to the molecular mechanisms of adrenal tumors. 

Research Interest

1. Study of the effects of GLP-1R agonists in the adipose tissue
2. Role of the adipose in the adrenal tumour microenvironment
3. Isolation and morphological and functional characterization of human adult stem cells from visceral and subcutaneous adipose tissue biopsies, from the same subject
4. Molecular mechanisms underlying adrenocortical cancer progression
5. Study of anti-diabetes drug signaling pathways (thiazolidinediones)
6. Toxicity studies of immunosuppressive drugs, in an in vitro endothelial cell model
7. Molecular mechanisms underlying endothelial dysfunction
8. Adiponectin anti-inflammatory effects in different human cell models 

Leave Your Message 24x7
Top